When people stop a GLP-1 medicine, much of the weight usually comes back. In the STEP 1 trial extension, adults who stopped semaglutide 2.4 mg (Wegovy) regained about two thirds of the weight they had lost within one year. In SURMOUNT-4, people switched from tirzepatide (Zepbound) to placebo regained 14% of their body weight over the next year, while those who stayed on it lost another 5.5%. That is not a personal failure: appetite returns and the body defends its old weight, so any plan to stop, taper or stay on a maintenance dose is one to make with your clinician.
Key takeaways
- In the STEP 1 extension, people lost an average of 17.3% of body weight on semaglutide over 68 weeks, then regained 11.6 percentage points in the year after stopping, about two thirds of the loss.
- In SURMOUNT-4, after 36 weeks on tirzepatide (an average loss of 20.9%), those switched to placebo regained 14.0% of body weight by week 88; those who continued lost a further 5.5%.
- At week 88 of SURMOUNT-4, 89.5% of people still on tirzepatide had kept at least 80% of their earlier loss, compared with 16.6% on placebo.
- Even after regain, people in both trials were, on average, still below their starting weight.
- Whether to stop, taper, or stay on a lower dose is a decision for you and your prescriber. Follow your prescriber and the label.
- Habits built during treatment (protein, strength training, sleep, regular weighing) are the ones that carry over.
What happens to your weight after you stop a GLP-1?
Most people regain a meaningful part of the weight within a year, and the two largest trials that studied this show it clearly. Both were run by the drug makers and both had people stop the medicine without a structured plan for afterwards, so they show what happens when treatment simply ends.
| Trial | Medicine | Loss while on treatment | What happened after | Net change at the end |
|---|---|---|---|---|
| STEP 1 extension (327 people) | Semaglutide 2.4 mg, stopped at week 68 | 17.3% average loss by week 68 | Regained 11.6 percentage points by week 120 | About 5.6% below starting weight |
| SURMOUNT-4 (670 people) | Tirzepatide 10 or 15 mg, switched to placebo at week 36 | 20.9% average loss by week 36 | Regained 14.0% of body weight by week 88 | About 9.9% below starting weight |
| SURMOUNT-4, continued | Tirzepatide kept going | 20.9% by week 36 | Lost a further 5.5% by week 88 | About 25.3% below starting weight |
Two things stand out. First, regain was the usual outcome, not the exception. Second, it was not total: on average, people did not go all the way back to where they started within that year. The STEP 1 extension also found that improvements in blood pressure, blood sugar and cholesterol moved back toward where they began after stopping.
These are averages. Some people kept off much more, some regained more. The trials do not tell you what will happen to you, only what tends to happen when the medicine stops and nothing else changes.
Why does the weight come back?
Weight comes back mainly because the medicine was doing work that your body does not keep doing on its own. GLP-1 medicines quiet hunger and help you feel full sooner. When the drug leaves your system, over a few weeks, that signal fades and your appetite returns to something closer to how it was before.
At the same time, your body tends to defend its previous weight. After weight loss, hunger hormones usually rise and the body burns a little less energy than you might expect for your new size. Obesity is now understood as a chronic condition, which is why the authors of both trials concluded that ongoing treatment is often needed to keep the results.
Knowing this helps in two ways. It explains why "just use willpower" is poor advice, and it shows why the time to plan for after is while you are still on treatment.
Should I taper off or stay on a maintenance dose?
That is a decision for you and your prescriber, not something to work out alone. Some people stay on long term, some move to a lower dose, some stop, and the right path depends on your health, your goals, side effects, access and cost. The labels for Wegovy and Zepbound describe the approved doses; they do not set out a tapering schedule, so follow your prescriber and the label.
Questions worth bringing to that appointment:
- What do we expect to happen to my weight and my numbers (blood pressure, A1C, cholesterol) if I stop?
- Is a lower dose an option for me, and how would we decide?
- How often should we check in during the first months off treatment?
- What change on the scale should make me call you?
- If I regain, is restarting an option?
Bringing a record of your weight, side effects and labs makes the conversation faster and more specific.
What habits help keep the weight off after a GLP-1?
The habits that help most are the ones you build while the medicine is still making things easier. They will not fully replace what the drug does, but they give you the best footing.
Protein at every meal. Protein helps protect muscle while you lose weight and keeps you fuller. Many people eat less of it on a GLP-1 simply because they eat less overall. A clinician or dietitian can help you set a daily target; the protein calculator gives a starting point to discuss.
Strength training. Some of the weight lost on any diet or medicine is lean mass. Regular resistance exercise, such as weights, bands or bodyweight moves, helps you keep muscle, which matters for strength, balance and how you feel day to day. Our guide on muscle loss covers this in more detail.
Sleep. Short or broken sleep tends to raise hunger and cravings the next day. A regular bedtime is one of the cheapest supports you have.
Regular weighing. Weighing yourself on a regular schedule, under the same conditions, lets you see a trend early instead of being surprised months later. The aim is information, not judgment.
An early warning range. Agree with your clinician on a range around your current weight. If your trend moves past the top of that range, it is a signal to act early: review meals, protein and sleep, and book a check-in. Small, early steps are easier than large, late ones.
Meals that still work without the medicine. Notice which meals kept you full on treatment, usually ones built around protein, vegetables and fiber. Our guide on what to eat has ideas.
How do I handle the emotional side of stopping?
Expect mixed feelings, and know they are normal. Many people feel fear of losing what they worked for, relief at being done with shots, or frustration when hunger comes back louder than they remember. None of these mean you did anything wrong.
If the scale moves up, it is your body responding the way the trials predict, not proof that you failed. Try to talk to yourself the way you would talk to a friend. Notice the hunger without arguing with it, eat a real meal with protein, and look at your trend over weeks rather than any single morning.
It can also help to name what you gained beyond the number: steadier energy, new meals you like, a strength routine, a better sense of fullness. Those are yours to keep.
If food thoughts start to feel constant, or you notice you are restricting, bingeing or feeling low for more than a couple of weeks, tell your clinician. Support for eating and mood is part of good care, not a sign of weakness.
When should I talk to a clinician after stopping?
Talk to your clinician before you stop, and again soon after. Stopping is best planned, not done on your own, and some people have conditions such as type 2 diabetes or high blood pressure where their other medicines may need review once a GLP-1 is no longer working in the background.
Reach out sooner if:
- your weight passes the top of the range you agreed on
- your blood sugar, if you check it, starts running higher
- hunger or food thoughts feel hard to manage
- you notice low mood, anxiety, or changes in eating that worry you
If you have severe stomach pain that will not go away, pain that spreads to your back, vomiting you cannot stop, signs of severe dehydration, yellowing of your skin or eyes, a lump in your neck, or signs of an allergic reaction, contact your clinician or seek urgent care right away, whether you are on the medicine, tapering, or recently stopped.
How Morning helps
Morning is built to be with you before, during and after treatment. Weight and progress charts, synced with Apple Health, show your trend so you notice drift early, and the AI food photo scan counts protein, fiber and water toward your daily targets. When you are deciding about stopping or a lower dose, the doctor report puts your weight, side effects and lab results in one place to bring to your appointment. Ask Sunny is there for food and side-effect questions any time, and never gives dose advice.
Download for iOS7 days free · English and Spanish
Questions
Will I regain all the weight if I stop Wegovy or Zepbound?
Not necessarily all of it. In the STEP 1 extension, people regained about two thirds of their semaglutide weight loss within a year, and in SURMOUNT-4 people switched to placebo were still about 9.9% below their starting weight at week 88. Results vary a lot from person to person.
How fast does weight come back after stopping a GLP-1?
In both trials, weight started rising in the months after stopping and kept rising over the following year. Appetite usually returns over a few weeks as the drug leaves your system, so the early months are when a plan matters most.
Can I taper off a GLP-1 to avoid regain?
Whether and how to taper is a decision for your prescriber. The Wegovy and Zepbound labels do not set out a tapering schedule, and the main withdrawal trials studied stopping, not tapering, so follow your prescriber and the label.
What is the best diet after stopping a GLP-1?
There is no single best diet. Meals built around protein, vegetables and fiber, eaten at regular times, tend to keep people fuller, and pairing them with strength training helps protect muscle. A dietitian can help you tailor this.
Is it a failure if I regain weight after stopping?
No. The trials show regain is the common outcome because appetite returns and the body defends its weight. It is a medical pattern, not a character flaw, and it is worth discussing with your clinician without shame.
Sources
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. doi.org/10.1111/dom.14725
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 2024;331(1):38-48. jamanetwork.com
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021. doi.org/10.1056/NEJMoa2032183
- Wegovy (semaglutide) prescribing information, FDA. DailyMed
- Zepbound (tirzepatide) prescribing information, FDA. DailyMed
Keep reading
Educational information, not medical advice. Talk to your clinician about your treatment.